{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:57:37Z","timestamp":1778813857604,"version":"3.51.4"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504486"],"award-info":[{"award-number":["82504486"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Project of Research and Development Program of China","award":["2021YFC2500404, 2021YFC2500405"],"award-info":[{"award-number":["2021YFC2500404, 2021YFC2500405"]}]},{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["subcontract of UM1 CA173640"],"award-info":[{"award-number":["subcontract of UM1 CA173640"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The association between adiposity and increased liver cancer risk is well-recognized, yet underlying metabolic mechanisms require elucidation. This study aimed to identify metabolic mediators linking adiposity markers to liver cancer and assess their potential causality using two-sample Mendelian randomization (MR) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      We conducted a 1:1 matched nested case-control study within a population-based and prospective cohort study\u2014the Shanghai Men\u2019s Health Study (SMHS). The SMHS was initiated in 2002\u20132006, including 61,469 Chinese men aged 40\u201374 years, and has been followed up for over 20 years. Targeted metabolomic profiling was performed on baseline plasma samples. Associations between seven anthropometric measurements (body mass index [BMI], waist circumference, waist-to-hip ratio, waist-to-height ratio, a body shape index, hip circumference, and adult weight gain), 186 circulating metabolites, and liver cancer risk were assessed. Linear and conditional logistic regression model adjusted for multiple confounders (including smoking, alcohol drinking, physical activity, chronic hepatitis and cirrhosis, diabetes, etc.) were used. Pathway analysis and network analysis were conducted to explore the biological functions of these metabolites. Parallel mediation analysis was employed to quantify the mediating effects through metabolites. Subsequently, MR analysis was performed to investigate potential causal relationships. This study incorporated 322 incident liver cancer cases and 322 cancer-free controls. Participants diagnosed with liver cancer had higher proportions of seropositive hepatitis B surface antigen (63.7%) compared to their matched controls (6.2%). We identified 27 intermediate metabolites associated with both adiposity markers and liver cancer risk, which formed an interconnected functional network. Pyroglutamic acid demonstrated the most robust consistency, being significantly associated with seven anthropometric measurements (\u03b2 per doubling with BMI\u2009=\u20090.17; 95% confidence interval [CI]: [0.09, 0.24]) and liver cancer (odds ratio per doubling\u2009=\u20091.56; 95% CI: [1.13, 2.15]). Pathway analysis highlighted significant alterations in energy, lipid, and amino acid metabolism. Specifically, Phenylalanine, tyrosine, and tryptophan biosynthesis showed the highest impact, suggesting a key role for aromatic amino acid metabolism. Parallel mediation analysis demonstrated significant indirect effects via intermediate metabolites for six of the seven anthropometric measurements, with the proportion mediated by the identified metabolite clusters reaching 0.16 (95% CI: [0.05, 0.29]) for BMI. MR analysis provided evidence supporting potential causality for 23 of 108 initially observed associations. The strongest association was observed between WC and oxoglutaric acid (\u03b2\n                      <jats:sub>IVW<\/jats:sub>\n                      per standard deviation\u2009=\u20090.31; 95% CI: [0.17, 0.43]). Notably, while the observational analysis suggested a broad metabolic mediation of the adiposity marker-liver cancer association, the MR findings pinpointed a more specific and limited set of causal metabolic mediators. The main limitation of this study was the population mismatch between the observational (Chinese men) and the MR (European ancestry) analyses, which may limit the generalizability of the findings to other populations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Integrating prospective observational and genetic evidence, we identified specific metabolic mediators linking adiposity to liver cancer, particularly involving amino acid, lipid and energy metabolism. These findings enhanced molecular understanding of adiposity-driven hepatocarcinogenesis and provided potential metabolic targets for future primary prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1004910","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T18:38:36Z","timestamp":1770057516000},"page":"e1004910","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolomic insights into associations between adiposity markers and liver cancer risk: Results from a prospective cohort study and Mendelian randomization analysis"],"prefix":"10.1371","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4592-7136","authenticated-orcid":true,"given":"Zhuo-Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0308-0846","authenticated-orcid":true,"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Ming","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Xin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1394-2215","authenticated-orcid":true,"given":"Dan-Ni","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7039-6608","authenticated-orcid":true,"given":"Yu-Ting","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3840-9915","authenticated-orcid":true,"given":"Yong-Bing","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"3","key":"pmed.1004910.ref001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"pmed.1004910.ref002","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2018.12.001","article-title":"The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention","volume":"70","author":"Z Liu","year":"2019","journal-title":"J Hepatol"},{"key":"pmed.1004910.ref003","article-title":"From non-A, non-B hepatitis to hepatitis C virus cure","volume":"62","author":"J-M Pawlotsky","year":"2015","journal-title":"J Hepatol"},{"issue":"10","key":"pmed.1004910.ref004","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/1055-9965.EPI-24-0686","article-title":"Liver cancer: progress and priorities","volume":"33","author":"KA McGlynn","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"pmed.1004910.ref005","doi-asserted-by":"crossref","first-page":"155326","DOI":"10.1016\/j.metabol.2022.155326","article-title":"Body fatness associations with cancer: evidence from recent epidemiological studies and future directions","volume":"137","author":"SC Larsson","year":"2022","journal-title":"Metabolism"},{"issue":"3","key":"pmed.1004910.ref006","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ijc.27645","article-title":"Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort","volume":"132","author":"S Schlesinger","year":"2013","journal-title":"Int J Cancer"},{"issue":"6","key":"pmed.1004910.ref007","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1158\/1055-9965.EPI-20-1610","article-title":"Dose-response association between adiposity and liver cancer incidence: a prospective cohort study among non-smoking and non-alcohol-drinking Chinese women","volume":"30","author":"Z-Y Li","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"pmed.1004910.ref008","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12916-021-02188-x","article-title":"Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies","volume":"19","author":"SC Larsson","year":"2021","journal-title":"BMC Med"},{"issue":"7","key":"pmed.1004910.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003706","article-title":"Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: a mendelian randomisation study","volume":"18","author":"M Vithayathil","year":"2021","journal-title":"PLoS Med"},{"issue":"11","key":"pmed.1004910.ref010","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41575-018-0038-1","article-title":"Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions","volume":"15","author":"N Murphy","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"pmed.1004910.ref011","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2013.09.001","article-title":"Obesity and liver cancer","volume":"18","author":"E Vanni","year":"2014","journal-title":"Clin Liver Dis"},{"key":"pmed.1004910.ref012","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-3-319-42542-9_11","article-title":"Obesity biomarkers, metabolism and risk of cancer: an epidemiological perspective","volume":"208","author":"K Nimptsch","year":"2016","journal-title":"Recent Results Cancer Res"},{"issue":"2","key":"pmed.1004910.ref013","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.09.022","article-title":"Profound perturbation of the metabolome in obesity is associated with health risk","volume":"29","author":"ET Cirulli","year":"2019","journal-title":"Cell Metab"},{"issue":"1","key":"pmed.1004910.ref014","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/oby.22670","article-title":"Metabolomic profiles associated with bmi, waist circumference, and diabetes and inflammation biomarkers in women","volume":"28","author":"VL Stevens","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"pmed.1004910.ref015","doi-asserted-by":"crossref","first-page":"104990","DOI":"10.1016\/j.ebiom.2024.104990","article-title":"Prediagnostic plasma metabolite concentrations and liver cancer risk: a population-based study of Chinese men","volume":"100","author":"Z-Y Li","year":"2024","journal-title":"EBioMedicine"},{"key":"pmed.1004910.ref016","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12916-015-0462-9","article-title":"Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort","volume":"13","author":"A Fages","year":"2015","journal-title":"BMC Med"},{"issue":"10","key":"pmed.1004910.ref017","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1158\/1055-9965.EPI-07-0457","article-title":"Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old","volume":"16","author":"P Vineis","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"pmed.1004910.ref018","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/1354750X.2010.533285","article-title":"Meeting-in-the-middle using metabolic profiling\u2014a strategy for the identification of intermediate biomarkers in cohort studies","volume":"16","author":"M Chadeau-Hyam","year":"2011","journal-title":"Biomarkers"},{"issue":"10","key":"pmed.1004910.ref019","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s42255-023-00903-x","article-title":"Metabolomic epidemiology offers insights into disease aetiology","volume":"5","author":"H Fuller","year":"2023","journal-title":"Nat Metab"},{"key":"pmed.1004910.ref020","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"G Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"6","key":"pmed.1004910.ref021","first-page":"1866","article-title":"Triangulation in aetiological epidemiology","volume":"45","author":"DA Lawlor","year":"2016","journal-title":"Int J Epidemiol"},{"key":"pmed.1004910.ref022","doi-asserted-by":"crossref","first-page":"102091","DOI":"10.1016\/j.canep.2021.102091","article-title":"Dose-response relationship between fat distribution and liver cancer incidence: a prospective cohort study in Chinese men","volume":"76","author":"Z-Y Li","year":"2022","journal-title":"Cancer Epidemiol"},{"issue":"9596","key":"pmed.1004910.ref023","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"E von Elm","year":"2007","journal-title":"Lancet"},{"issue":"16","key":"pmed.1004910.ref024","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement","volume":"326","author":"VW Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"pmed.1004910.ref025","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ije\/dyv013","article-title":"Cohort profile: the Shanghai men\u2019s health study","volume":"44","author":"X-O Shu","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"14","key":"pmed.1004910.ref026","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1021\/acs.analchem.0c04686","article-title":"A metabolite array technology for precision medicine","volume":"93","author":"G Xie","year":"2021","journal-title":"Anal Chem"},{"issue":"6","key":"pmed.1004910.ref027","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: the R package \u201cdagitty\u201d","volume":"45","author":"J Textor","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"1","key":"pmed.1004910.ref028","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"J R Stat Soc B Stat Methodol"},{"issue":"5","key":"pmed.1004910.ref029","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/sim.4780080504","article-title":"Flexible regression models with cubic splines","volume":"8","author":"S Durrleman","year":"1989","journal-title":"Stat Med"},{"issue":"9","key":"pmed.1004910.ref030","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/sim.3841","article-title":"Dose-response analyses using restricted cubic spline functions in public health research","volume":"29","author":"L Desquilbet","year":"2010","journal-title":"Stat Med"},{"issue":"4","key":"pmed.1004910.ref031","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nmeth0410-247","article-title":"Predicting causal effects in large-scale systems from observational data","volume":"7","author":"MH Maathuis","year":"2010","journal-title":"Nat Methods"},{"issue":"11","key":"pmed.1004910.ref032","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v047.i11","article-title":"Causal inference using graphical models with the R package pcalg","volume":"47","author":"M Kalisch","year":"2012","journal-title":"J Stat Soft"},{"key":"pmed.1004910.ref033","first-page":"1","article-title":"The igraph software","volume":"1695","author":"G Cs\u00e1rdi","year":"2006","journal-title":"Complex Syst"},{"key":"pmed.1004910.ref034","volume-title":"igraph for R: R interface of the igraph library for graph theory and network analysis","author":"G Cs\u00e1rdi","year":"2024"},{"key":"pmed.1004910.ref035","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Z Pang","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pmed.1004910.ref036","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"M Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"pmed.1004910.ref037","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt1067","article-title":"SMPDB 2.0: big improvements to the Small Molecule Pathway Database","volume":"42","author":"T Jewison","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"pmed.1004910.ref038","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkab1062","article-title":"HMDB 5.0: the Human Metabolome Database for 2022","volume":"50","author":"DS Wishart","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"pmed.1004910.ref039","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gky299","article-title":"iPath3.0: interactive pathways explorer v3","volume":"46","author":"Y Darzi","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"pmed.1004910.ref040","volume-title":"Introduction to mediation, moderation, and conditional process analysis: a regression-based approach","author":"AF Hayes","year":"2017"},{"key":"pmed.1004910.ref041","article-title":"ClustOfVar: an R package for the clustering of variables","author":"M Chavent","year":"2011","journal-title":"arXiv"},{"issue":"7944","key":"pmed.1004910.ref042","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"MI Kurki","year":"2023","journal-title":"Nature"},{"issue":"20","key":"pmed.1004910.ref043","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","article-title":"Meta-analysis of genome-wide association studies for height and body mass index in \u223c700000 individuals of European ancestry","volume":"27","author":"L Yengo","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"7726","key":"pmed.1004910.ref044","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"C Bycroft","year":"2018","journal-title":"Nature"},{"key":"pmed.1004910.ref045","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/hmg\/ddy327","article-title":"Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.","volume":"28","author":"SL Pulit","year":"2019","journal-title":"Hum Mol Genet"},{"key":"pmed.1004910.ref046","unstructured":"Mitchell RE. MRC IEU UK Biobank GWAS pipeline version 2. In: data.bris [Internet]. 20 Feb 2019 [cited 14 Oct 2024]. https:\/\/doi.org\/10.5523\/bris.pnoat8cxo0u52p6ynfaekeigi"},{"issue":"1","key":"pmed.1004910.ref047","doi-asserted-by":"crossref","first-page":"10688","DOI":"10.1038\/s41598-021-89176-6","article-title":"GWAS of allometric body-shape indices in UK Biobank identifies loci suggesting associations with morphogenesis, organogenesis, adrenal cell renewal and cancer","volume":"11","author":"S Christakoudi","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"pmed.1004910.ref048","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases","volume":"55","author":"Y Chen","year":"2023","journal-title":"Nat Genet"},{"issue":"6","key":"pmed.1004910.ref049","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/ije\/dyz173","article-title":"Cohort profile: the Canadian Longitudinal Study on Aging (CLSA)","volume":"48","author":"P Raina","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"1","key":"pmed.1004910.ref050","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2013.06.013","article-title":"A genome-wide association study of the human metabolome in a community-based cohort","volume":"18","author":"EP Rhee","year":"2013","journal-title":"Cell Metab"},{"issue":"7","key":"pmed.1004910.ref051","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"S Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"issue":"2","key":"pmed.1004910.ref052","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"J Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"4","key":"pmed.1004910.ref053","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"J Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"6","key":"pmed.1004910.ref054","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption","volume":"46","author":"FP Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"pmed.1004910.ref055","doi-asserted-by":"crossref","DOI":"10.1201\/9780429324352","volume-title":"Mendelian randomization: methods for causal inference using genetic variants","author":"S Burgess","year":"2021","edition":"2"},{"issue":"4","key":"pmed.1004910.ref056","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects","volume":"181","author":"S Burgess","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"5","key":"pmed.1004910.ref057","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","article-title":"Mendelian randomisation for mediation analysis: current methods and challenges for implementation","volume":"36","author":"AR Carter","year":"2021","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"pmed.1004910.ref058","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1055-9965.EPI-17-0649","article-title":"Are metabolic signatures mediating the relationship between lifestyle factors and hepatocellular carcinoma risk? Results from a nested case-control study in EPIC","volume":"27","author":"N Assi","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"pmed.1004910.ref059","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cgh.2013.07.040","article-title":"Insulin resistance, obesity, and liver cancer","volume":"12","author":"G Farrell","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"pmed.1004910.ref060","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jhep.2011.09.020","article-title":"Obesity, inflammation, and liver cancer","volume":"56","author":"B Sun","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"pmed.1004910.ref061","doi-asserted-by":"crossref","first-page":"100479","DOI":"10.1016\/j.jhepr.2022.100479","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"B Paul","year":"2022","journal-title":"JHEP Rep"},{"issue":"4","key":"pmed.1004910.ref062","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3390\/ijms22042163","article-title":"Association of adipose tissue and adipokines with development of obesity-induced liver cancer","volume":"22","author":"Y Rajesh","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"pmed.1004910.ref063","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nrgastro.2017.72","article-title":"The gut microbiome and liver cancer: mechanisms and clinical translation","volume":"14","author":"L-X Yu","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"pmed.1004910.ref064","doi-asserted-by":"crossref","first-page":"648","DOI":"10.2337\/dc12-0895","article-title":"Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults","volume":"36","author":"P W\u00fcrtz","year":"2013","journal-title":"Diabetes Care"},{"issue":"11","key":"pmed.1004910.ref065","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.tem.2020.02.012","article-title":"Gut microbial metabolites of aromatic amino acids as signals in host-microbe interplay","volume":"31","author":"Y Liu","year":"2020","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"pmed.1004910.ref066","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1382-6689(01)00078-3","article-title":"The biochemistry of selenium and the glutathione system","volume":"10","author":"GE Arteel","year":"2001","journal-title":"Environ Toxicol Pharmacol"},{"issue":"4","key":"pmed.1004910.ref067","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","article-title":"Role of mitochondrial dysfunction in insulin resistance","volume":"102","author":"J-A Kim","year":"2008","journal-title":"Circ Res"},{"issue":"1","key":"pmed.1004910.ref068","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40139-012-0003-6","article-title":"Bile acid receptors and liver cancer","volume":"1","author":"X Wang","year":"2013","journal-title":"Curr Pathobiol Rep"},{"key":"pmed.1004910.ref069","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mito.2018.02.009","article-title":"Mitochondrial \u03b2-oxidation of saturated fatty acids in humans","volume":"46","author":"MM Adeva-Andany","year":"2019","journal-title":"Mitochondrion"},{"issue":"1","key":"pmed.1004910.ref070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12885-025-13690-3","article-title":"Causality of blood metabolites on hepatocellular carcinoma and cholangiocarcinoma: a metabolome-wide mendelian randomization study","volume":"25","author":"L Ning","year":"2025","journal-title":"BMC Cancer"},{"issue":"11","key":"pmed.1004910.ref071","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1373\/clinchem.2012.199133","article-title":"Reproducibility of metabolomic profiles among men and women in 2 large cohort studies","volume":"59","author":"MK Townsend","year":"2013","journal-title":"Clin Chem"},{"issue":"8","key":"pmed.1004910.ref072","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135437","article-title":"Reliability of serum metabolites over a two-year period: a targeted metabolomic approach in fasting and non-fasting samples from EPIC","volume":"10","author":"M Carayol","year":"2015","journal-title":"PLoS One"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T18:38:49Z","timestamp":1770057529000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004910"}},"subtitle":[],"editor":[{"given":"Steven C","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":72,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004910","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}